These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

915 related articles for article (PubMed ID: 24944467)

  • 1. Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine.
    Saha L
    World J Gastroenterol; 2014 Jun; 20(22):6759-73. PubMed ID: 24944467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of irritable bowel syndrome in China: a review.
    Li CY; Li SC
    World J Gastroenterol; 2015 Feb; 21(8):2315-22. PubMed ID: 25741137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of irritable bowel syndrome.
    Trinkley KE; Nahata MC
    J Clin Pharm Ther; 2011 Jun; 36(3):275-82. PubMed ID: 21545610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irritable bowel syndrome - from etiopathogenesis to therapy.
    Radovanovic-Dinic B; Tesic-Rajkovic S; Grgov S; Petrovic G; Zivkovic V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2018 Mar; 162(1):1-9. PubMed ID: 29358788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research.
    Fehnel SE; Ervin CM; Carson RT; Rigoni G; Lackner JM; Coons SJ;
    Value Health; 2017 Apr; 20(4):618-626. PubMed ID: 28408004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptom Severity Following Rifaximin and the Probiotic VSL#3 in Patients with Chronic Pelvic Pain Syndrome (Due to Inflammatory Prostatitis) Plus Irritable Bowel Syndrome.
    Vicari E; Salemi M; Sidoti G; Malaguarnera M; Castiglione R
    Nutrients; 2017 Nov; 9(11):. PubMed ID: 29099760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in pharmacological treatment of irritable bowel syndrome.
    Lazaraki G; Chatzimavroudis G; Katsinelos P
    World J Gastroenterol; 2014 Jul; 20(27):8867-85. PubMed ID: 25083060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation.
    Singh P; Staller K; Barshop K; Dai E; Newman J; Yoon S; Castel S; Kuo B
    World J Gastroenterol; 2015 Jul; 21(26):8103-9. PubMed ID: 26185382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irritable bowel syndrome: epidemiology, diagnosis and treatment: an update for health-care practitioners.
    Grundmann O; Yoon SL
    J Gastroenterol Hepatol; 2010 Apr; 25(4):691-9. PubMed ID: 20074154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.
    Evans BW; Clark WK; Moore DJ; Whorwell PJ
    Cochrane Database Syst Rev; 2007 Oct; (4):CD003960. PubMed ID: 17943807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtypes of irritable bowel syndrome on Rome III criteria: a multicenter study.
    Yao X; Yang YS; Cui LH; Zhao KB; Zhang ZH; Peng LH; Guo X; Sun G; Shang J; Wang WF; Feng J; Huang Q
    J Gastroenterol Hepatol; 2012 Apr; 27(4):760-5. PubMed ID: 21929652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irritable Bowel Syndrome: Epidemiology, Pathophysiology, Diagnosis, and Treatment.
    Defrees DN; Bailey J
    Prim Care; 2017 Dec; 44(4):655-671. PubMed ID: 29132527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of symptoms in irritable bowel syndrome with mixed bowel habit pattern.
    Su AM; Shih W; Presson AP; Chang L
    Neurogastroenterol Motil; 2014 Jan; 26(1):36-45. PubMed ID: 23991913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irritable bowel syndrome: a clinical review.
    Chey WD; Kurlander J; Eswaran S
    JAMA; 2015 Mar; 313(9):949-58. PubMed ID: 25734736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Narrative Review of Irritable Bowel Syndrome with Diarrhea: A Primer for Primary Care Providers.
    Moshiree B; Heidelbaugh JJ; Sayuk GS
    Adv Ther; 2022 Sep; 39(9):4003-4020. PubMed ID: 35869354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing the Use of Linaclotide in Patients with Constipation-Predominant Irritable Bowel Syndrome: An Expert Consensus Report.
    Rey E; Mearin F; Alcedo J; Ciriza C; Delgado-Aros S; Freitas T; Mascarenhas M; Mínguez M; Santos J; Serra J
    Adv Ther; 2017 Mar; 34(3):587-598. PubMed ID: 28083815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irritable bowel syndrome in children: pathogenesis, diagnosis and evidence-based treatment.
    Sandhu BK; Paul SP
    World J Gastroenterol; 2014 May; 20(20):6013-23. PubMed ID: 24876724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A comparison between Rome III and Rome II criteria in diagnosing irritable bowel syndrome].
    Wang AJ; Liao XH; Hu PJ; Liu SC; Xiong LS; Chen MH
    Zhonghua Nei Ke Za Zhi; 2007 Aug; 46(8):644-7. PubMed ID: 17967234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updated review of current pharmacological and non-pharmacological management of irritable bowel syndrome.
    Rawla P; Sunkara T; Raj JP
    Life Sci; 2018 Nov; 212():176-181. PubMed ID: 30290187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of functional constipation and constipation predominant irritable bowel syndrome based on Rome III criteria: a population-based study.
    Koloski NA; Jones M; Young M; Talley NJ
    Aliment Pharmacol Ther; 2015 May; 41(9):856-66. PubMed ID: 25736433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.